Characteristic | Low scores (n = 39) | High scores (n = 40) | p. value |
---|---|---|---|
No. (%) | No. (%) | ||
Gender, n (%) | Â | Â | 0.511 |
 Female | 8 (10.1%) | 5 (6.3%) |  |
 Male | 31 (39.2%) | 35 (44.3%) |  |
T stage, n (%) | Â | Â | 0.039 |
 T1a | 13 (16.5%) | 5 (6.3%) |  |
 T1b | 12 (15.2%) | 12 (15.2%) |  |
 T2 | 13 (16.5%) | 16 (20.3%) |  |
 T3 | 1 (1.3%) | 7 (8.9%) |  |
N stage, n (%) | Â | Â | 0.615 |
 N0 | 37 (46.8%) | 39 (49.4%) |  |
 N1 | 2 (2.5%) | 1 (1.3%) |  |
M status, n (%) | Â | Â | 0.066 |
 M0 | 37 (46.8%) | 31 (39.2%) |  |
 M1 | 2 (2.5%) | 8 (10.1%) |  |
 M2 | 0 (0%) | 1 (1.3%) |  |
HBsAg, n (%) | Â | Â | 0.953 |
 Negative | 9 (11.4%) | 8 (10.1%) |  |
 Positive | 30 (38%) | 32 (40.5%) |  |
HBcAb, n (%) | Â | Â | 1.000 |
 Negative | 7 (8.9%) | 7 (8.9%) |  |
 Positive | 32 (40.5%) | 33 (41.8%) |  |
Age, mean ± SD | 53.82 ± 9.37 | 50.38 ± 12.66 | 0.173 |